Monday, June 20, 2016
Monday, June 13, 2016
Slowing Nearsighted Progression
About Nearsighted or Myopic Progression
Myopia is a common disorder, affecting approximately one-third of the U.S. population. High myopia is associated with an increased risk of sight-threatening problems, such as retinal detachment, choroidal degeneration, cataracts, and glaucoma. Slowing the progression of myopia could potentially benefit millions of children in the U.S. To date, few clinical approaches for myopia control and slowing myopic progression have proven to be consistently effective. Treatment options such as undercorrection of myopia, gas permeable contact lenses, and bifocal or multifocal spectacles have all been proven to be ineffective for myopia control, although one recent clinical trial using executive top bifocal spectacles on children with progressive myopia has shown to decrease the progression to nearly half of the control subjects. The most effective methods are the use of orthokeratology contact lenses, soft bifocal contact lenses, and certain eye drops not specifically approved for this use. We encourage parents children experiencing rapid myopic progression to discuss which if any of these options might be helpful or appropriate for their children.
If you or someone you know has a question about myopic progression or the ways to slow nearsighted prescription increases, feel free to discuss your concerns with us and please call Doctor & Associates-203-227-4113, visit Doctor & Associates in Fairfield County, Google+ or facebook.com/doctorandassociates to schedule an appointment.
Doctor & Associates offices are located at 129 Kings Highway North, Westport, Connecticut 06880, 195 Danbury Road, Wilton, Connecticut 06897 and 148 East Avenue, Norwalk, Connecticut 06851.
Monday, June 6, 2016
Retinitis Pigmentosa Help
About Retinitis Pigmentosa
Retinitis pigmentosa (RP) is a progressive inherited disease of the eye, in which the light-sensitive photoreceptor cells located in the retina degenerate. This results first in the loss of night and peripheral vision, eventually progressing to the loss of central vision and total blindness. It is the leading cause of inherited blindness in the developed world.
The disease, which affects approximately 1.5 million people in the world, has no cure, but thanks to research done at the University of California-Santa Barbara, a new stem cell therapy may soon be available that protects photoreceptor cells from the damaging effects of the gene mutation. So far, only a small number of legally blind patients with RP have begun a trial. The trial is the first attempt to use stem cells to prevent the loss of vision from RP. An experimental injection of retinal stem cells is placed in the eye with the hope that the growth factors from these cells will protect the retinal cells and prevent them from dying, thus preserving the patient’s remaining vision.
If you, a family member or someone you know would like to learn more about Retinitis Pigmentosa or many new stem therapies being developed for diseases of the retina, please call Doctor & Associates-203-227-4113, visit Doctor & Associates in Fairfield County, Google+ or facebook.com/doctorandassociates to schedule an appointment.
Doctor & Associates offices are located at 129 Kings Highway North, Westport, Connecticut 06880, 195 Danbury Road, Wilton, Connecticut 06897 and 148 East Avenue, Norwalk, Connecticut 06851.
Subscribe to:
Posts (Atom)